Hey Klementina Österberg ...

... CEO at GU Holding, which awards SEK 120, 000 to three female entrepreneurs.

Viktigt steg framåt för europeisk forskning

Life science in Stockholm

Sweden has the fourth-largest biotech market in Europe. More than half of its biotechnology enterprise, some 460 companies, is located in the Stockholm region.

Diagnostics to deal with new diseases

Maria Brytting at the Swedish Institute for Infectious Disease Control, SMI, will share her experiences from April 2009 when the new influenza A virus, H1N1, was first reported globally.

From planning stage to handshake

"Partnering is an effective tool to get in touch with the decision makers high up in an organization's administration," says Camilla Huse Bondeson at Conlega. And according to her, rigorous planning is the way to succeed.

EU manar till gemensamt Alzheimersprojekt

EU-parlamentet har antagit en resolution om ett gemensamt forskningsprogram kring neurodegenerativa sjukdomar inom medlemsländerna. Ledamöterna vill bland annat se storskaliga kliniska och epidemiologiska studier på området.

37 miljoner till Neurosearch

En nyemission och en milstolpeersättning ger det danska bolaget totalt 67,2 miljoner danska kronor.

100 000 kronor till Alzheimersforskare

Laura Fratiglioni vid Karolinska institutet får Folksams pris för epidemiologisk forskning.

Sociala nervceller kan bota dövhet

Rörliga bilder på nervceller ger forskare nya perspektiv på hur nervceller beter sig. Resultaten kan komma att användas för att behandla hörselskador, exempelvis genom celltransplantation.

Ensamt på fritiden för gäststudenter

Internationella studenter är nöjda med nivån på de danska högskoleutbildningarna. Däremot är de mindre nöjda med den sociala miljön utanför föreläsningssalarna. Det visar en ny undersökning från danska vetenskapsministeriet.

Forskningsstöd missgynnar kvinnor

Fler män får stöd, och de får i genomsnitt mer pengar. De danska forskningsrådens sätt att fördela pengar förstärker könsskillnaderna i forskningsvärlden, enligt en ny rapport.

Hundra miljoner ska ge friskare barn

Världens största centrum för barns hälsa och välmående ska byggas upp vid Köpenhamns universitet, efter en rekordstor donation.

Major changes to the Q-Med board

The nomination committee wants to replace half of the existing board, including the current Chairman. An Extraordinary General Meeting will take place on February 4.

Faster sales but less profits for Probi

The probiotic company increases its turnover, and the net results are twice as large as last year.

Lundbeck divests companies

The company sells all shares in one listed company plus divests four small private equity funds, for a three-figured million sum.

Lytix calls in cash

Norwegian company Lytix Biopharma closes a USD 1.4 million funding round to finance new antimicrobial and oncology lead compounds.

Respiratorius hunts millions

The biopharmaceutical company Respiratorius has got a new CEO, who starts a public new share issue to catch almost SEK ten million.

Harmony prevents dementia

People who are active, outgoing and relaxed may be less likely to develop dementia, according to a new study from Karolinska Institutet.

Abbott expands by acquisition

An acquisition gives Abbott a leadership position in another large and growing medical device segment.

Schizophrenia and bipolar disorder are relatives

Schizophrenia and bipolar disorder have the same genetic causes, according to a study from Karolinska Institutet.

Medicult disclaims Swedish offer

The Norwegian company Medicult's Board is highly sceptical to the yesterday announced Vitrolife offer.

Vitrolife wants to acquire Medicult

The Swedish company Vitrolife intends to make en exchange offer to the shareholders of the Danish company Medicult to acquire all outstanding shares in the company.

DKK 1,3 billion for grand research

Danish Councils for Independent Research, DFF, will grant DKK 1,3 billion during 2009. Now has the application period started.

Medicult acquires embryo scanner

The Danish company Medicult signs an agreement with Novocellus to gain access to embryo selection technology.